Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Sergeant

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Frontiers in Cell and Developmental Biology|January 11, 2020
A Kinase Anchor Protein 4 Is Vulnerable to Oxidative Adduction in Male Germ CellsBrett Nixon, Ilana R Bernstein, Shenae L Cafe, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2007
Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticityHuifang Ma, Sylvain Lesné, Linda Kotilinek, et al.
Journal of Molecular Neuroscience : MN|January 24, 2003
Pin1: a therapeutic target in Alzheimer neurodegenerationMalika Hamdane, Caroline Smet, Anne-Véronique Sambo, et al.
Brain : a Journal of Neurology|June 25, 2004
A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24Isabelle Le Ber, Maria Martinez, Dominique Campion, et al.
Journal of Visualized Experiments : Jove|April 22, 2014
Consensus brain-derived protein, extraction protocol for the study of human and murine brain proteome using both 2D-DIGE and mini 2DE immunoblottingFrancisco-Jose Fernandez-Gomez, Fanny Jumeau, Maxime Derisbourg, et al.
Acta Neuropathologica Communications|July 21, 2016
Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutationAnthony Papegaey, Sabiha Eddarkaoui, Vincent Deramecourt, et al.
Journal of Neurology|February 1, 2022
Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1Robert Jr Laforce, Caroline Dallaire-Théroux, Annie M Racine, et al.
ACS Chemical Neuroscience|January 23, 2015
Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolismPatricia Melnyk, Valérie Vingtdeux, Stéphane Burlet, et al.
Therapie|December 15, 2010
[Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?]Luc Buée, David Blum, Stéphanie Bombois, et al.
Human Molecular Genetics|September 13, 2015
miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivoPascal Y Smith, Julia Hernandez-Rapp, Francis Jolivette, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Frontiers in Cell and Developmental Biology|January 11, 2020
A Kinase Anchor Protein 4 Is Vulnerable to Oxidative Adduction in Male Germ CellsBrett Nixon, Ilana R Bernstein, Shenae L Cafe, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2007
Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticityHuifang Ma, Sylvain Lesné, Linda Kotilinek, et al.
Journal of Molecular Neuroscience : MN|January 24, 2003
Pin1: a therapeutic target in Alzheimer neurodegenerationMalika Hamdane, Caroline Smet, Anne-Véronique Sambo, et al.
Brain : a Journal of Neurology|June 25, 2004
A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24Isabelle Le Ber, Maria Martinez, Dominique Campion, et al.
Journal of Visualized Experiments : Jove|April 22, 2014
Consensus brain-derived protein, extraction protocol for the study of human and murine brain proteome using both 2D-DIGE and mini 2DE immunoblottingFrancisco-Jose Fernandez-Gomez, Fanny Jumeau, Maxime Derisbourg, et al.
Acta Neuropathologica Communications|July 21, 2016
Reduced Tau protein expression is associated with frontotemporal degeneration with progranulin mutationAnthony Papegaey, Sabiha Eddarkaoui, Vincent Deramecourt, et al.
Journal of Neurology|February 1, 2022
Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1Robert Jr Laforce, Caroline Dallaire-Théroux, Annie M Racine, et al.
ACS Chemical Neuroscience|January 23, 2015
Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolismPatricia Melnyk, Valérie Vingtdeux, Stéphane Burlet, et al.
Therapie|December 15, 2010
[Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?]Luc Buée, David Blum, Stéphanie Bombois, et al.
Human Molecular Genetics|September 13, 2015
miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivoPascal Y Smith, Julia Hernandez-Rapp, Francis Jolivette, et al.
Pageof 10